PURE BIOSCIENCE, INC. (PURE) Form 8-K — Oct 20, 2026
$PUREForm 8-KItems 1.01, 3.02, 9.01Filed Oct 20, 2026, 4:15 PM ET0001493152-26-047762Original filing
PURE Bioscience completed a $555,000 private placement closing on October 15, 2026, issuing 10,183,486 common shares at $0.0545 per share to accredited investors under Section 4(a)(2) and Rule 506 of Regulation D. Board member Tom Y. Lee invested the entire $555,000 directly and through affiliates, and the transaction was approved by the disinterested members of the Board, making this a related-party financing. Proceeds are earmarked for general corporate purposes including R&D, administrative expenses, and working capital.
Key figures
- Net Proceeds
- approximately $555,000
- Gross Proceeds
- 555000
- Offering Price
- 0.0545
- Shares Offered
- 10183486
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.